Short Interest in Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) Declines By 64.3%

Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) was the recipient of a large decrease in short interest in the month of January. As of January 15th, there was short interest totaling 41,372 shares, a decrease of 64.3% from the December 31st total of 115,921 shares. Based on an average daily trading volume, of 21,596 shares, the days-to-cover ratio is presently 1.9 days. Based on an average daily trading volume, of 21,596 shares, the days-to-cover ratio is presently 1.9 days.

Conduit Pharmaceuticals Price Performance

Shares of NASDAQ:CDTTW traded down $0.00 during trading on Friday, hitting $0.01. The company’s stock had a trading volume of 35,751 shares, compared to its average volume of 30,513. The company has a 50-day moving average of $0.01 and a 200-day moving average of $0.01. Conduit Pharmaceuticals has a 12 month low of $0.01 and a 12 month high of $0.02.

About Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc, a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.